Accelerating diagnosis and drug development with better managed datasets
With the increasing digitalisation of research, facilities are experiencing steady growth in data volumes, bringing with it a need for scalable storage solutions.
A Laboratory Information Management System (LIMS) is software used by laboratories to create a central repository for storing, managing and accessing data.
As well as storing all essential data relating to samples and results, a LIMS can automate digital processes. This helps labs to optimise workflows, minimise human error, and efficiently analyse large amounts of complex data.
The result? Faster diagnosis times and development of new drugs.
Managing research and clinical data
Data is one of the most prized and valuable assets of a pharma, biotech, research or clinical laboratory. Therefore, the system used to collect, manage and analyse that data needs to be extremely robust, offering secure storage and flexible reporting capabilities. It's also important to be able to accurately analyse and manage samples, enabling the lab to carry out its core functions.
Historically, laboratories used spreadsheets to manage data and reporting.
This is simply no longer sufficient to meet the demands of modern laboratories; as well as being complicated, it's time-consuming and prone to error. When labs are dealing with the personal data of hundreds of thousands of patients, it's vital these standards are met.
Whilst data management systems exist in all industries, implementing one that is specifically designed for use by labs helps to ensure the immediate availability of all necessary data and security functions.
LIMS solutions can handle the large volumes of data created by labs while being reliable and scalable to cope with changing output requirements. They also offer versatile tools with automation capabilities for data monitoring, analysis and reporting.
Benefits of a LIMS
The main purpose of a LIMS is to improve data efficiency and accuracy by reducing manual operations.
It does this by managing large volumes of data quickly and efficiently whilst maintaining strict industry standards for laboratory data management.
Not only that, LIMS enables the automation of complex data analysis, reducing the need for repetitive lab data tasks, freeing up the time of skilled scientists for more skilled tasks.
An efficient LIMS can integrate seamlessly with other essential systems, which is vital for a lab to run smoothly. The best piece of equipment is useless to clinicians if it cannot be used in conjunction with other necessary technology.
Critically, a LIMS creates a single point of access to ensure data consistency, improving overall data quality and security across an organisation.
What is LIMS used for?
Some of the most common tasks supported by LIMS are:
Sample management: Modern labs often deal with huge numbers of samples that need to be analysed, and manual processes are susceptible to errors and delays. LIMS solutions help to track and trace individual samples by generating a barcode that technicians, at various stages of testing and analysis, can scan to retrieve existing details or record additional information.
Workflow management: High-quality, traceable results are essential to the success of any lab. By combining all your data in a single location that integrates with a wider network of collaborators, a LIMS empowers laboratories to better manage workflows, improve communication and increase outputs.
Materials management: Lab processing relies heavily on tracking materials used, typically reagents. A LIMS enables detailed monitoring of inventoried reagents, how much is on hand, lot numbers, expiration dates and reorder levels. Traditional stock management systems are designed for simple warehousing and distribution applications but aren't able to keep up with the complex laboratory environment. A LIMS allows for complete visibility of the entire lab, including fridges, multiple lab locations and disposal bins, as well as recording where a particular reagent lot was used and with what samples it was combined.
Inventory management: Laboratories are consistently under pressure to reduce their running costs while also maximising productivity. One of the most effective ways to do this is by improving inventory management, helping your lab to not only track resources but also to use them as efficiently as possible. The LIMS system supports the management of lab consumables, alerting you to low stock, preventing duplicate orders and managing shopping lists to minimise downtime and reduce costs.
Request management portal: A LIMS supports wider collaboration by making it easy to request, send, and receive samples through the integrated request portal. Authorised researchers and physicians can then securely track and access samples to improve and extend your research team.
Keeping up with an evolving landscape
Just like the fast-paced industries that use them, laboratory information management systems are continually evolving.
Digitalisation is having a major impact on biotech and pharma businesses managing research and clinical labs, especially when combining LIMS to manage lab operations, ELNs (Electronic Lab Notebooks) to document experimental processes, and SDMS (Scientific Data Management Systems) to handle data resulting from experiments.
"Accelerating diagnosis and drug development with better managed datasets" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Errore nel recupero dei dati
Effettua l'accesso per consultare il tuo portafoglio
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Android Authority
28 minutes ago
- Android Authority
Miss your 3DS XL? This dual-screened Android handheld is almost exactly the same size
TL;DR The dual-screened AYN Thor will have 6-inch and 3.92-inch AMOLED panels. That will likely make it slightly smaller than the New Nintendo 3DS XL. Pricing hasn't been revealed, but it could be a compelling alternative to expensive second-hand 3DS models. It's been less than a day since AYN announced the dual-screened Thor handheld, but it's already looking like an incredibly compelling device for Nintendo 3DS fans. Late last night, the company showed off the first key specs, and it's great news for anyone looking to replace their aging 3DS hardware. Several hours after announcing the console, the company revealed that it will feature a 6-inch FHD 120Hz AMOLED panel on the top, and a 3.92-inch 60Hz AMOLED panel on the bottom. That second screen is likely the same as the AYANEO Pocket DMG and Retroid Pocket Classic, and it's widely considered one of the best panels of its size. That said, the 8:7 aspect ratio will have some letterboxing on 3DS games and classic systems. It's slightly smaller than the secondary screen on the New Nintendo 3DS XL, which measures 4.18-inches, but larger than one on the non-XL model, which measures 3.02-inches. In any case, the resolution is significantly higher, so it should offer a significant step up in terms of visuals. Don't want to miss the best from Android Authority? Set us as a preferred source in Google Search to support us and make sure you never miss our latest exclusive reports, expert analysis, and much more. AYN As for the main screen, it's a massive improvement over the relatively puny 400 x 240 output on the 3DS. The 6-inch FHD 120Hz AMOLED panel is more than five times the resolution, although again, there will be small black bars on the sides due to the 3DS' unique 5:3 aspect ratio. There's also no stereoscopic 3D effect, although many users turned that off anyway. The higher refresh rate is nice for some systems, but it will likely be lost when emulating 3DS games. AYANEO claims that refresh rates are capped at 60Hz when using both screens on its upcoming Pocket DS handheld due to Android limitations. AYN hasn't said anything about this regarding the Thor, but it will likely have the same issue. The AYN Thor looks just as portable as the original 3DS hardware. While AYN hasn't revealed the exact dimensions of the Thor, we can get a rough estimate of the size from the top screen. If the renders are correct, it should come in slightly smaller than the New Nintendo 3DS XL, which measures roughly 5.6 inches by 3.17 inches when closed. It will almost assuredly be thicker, but at least it will retain the same pocketability. Moving the speakers to the bottom and removing the camera altogether enables the much larger screen. It's much smaller than the AYANEO Pocket DS, which features a 7-inch panel on top and a 5-inch panel on the bottom. That's good news for fans of the smaller size of the original 3DS model, which has exploded in price in the last few years. AYN hasn't revealed pricing for the Thor, but if it comes in cheaper than the $400 earlybird pricing on the Pocket DS, it would be an excellent option for anyone in the market for a used 3DS. AYN still hasn't revealed full specs, pricing, or a release date for the Thor, so stay tuned for more details in the coming weeks. Follow
Yahoo
an hour ago
- Yahoo
The Surprising Supplement That May Help with Weight Loss, According to a New Study
Reviewed by Dietitian Maria Laura Haddad-Garcia Key Points Turmeric supplements led to modest weight loss in people with type 2 diabetes. The effects were greater with higher doses or longer-term use. Benefits varied and were not a replacement for standard diabetes care. Type 2 diabetes is a complex condition where the body struggles to manage blood sugar levels. It's often linked to abdominal obesity and can lead to serious health problems like damage to the eyes, nerves, kidneys and heart. With over 536 million people affected globally in 2021 (and that number expected to rise), diabetes is a growing concern. Managing diabetes can be challenging, as no single treatment works for everyone, and traditional medications can be expensive or have side effects. This has led researchers to explore safer, more affordable alternatives. One promising option is turmeric, a bright yellow spice commonly used in cooking. Its active compound, curcumin, has shown potential benefits for diabetes, obesity and inflammation. However, research results have been mixed. While some studies show promising benefits, others have found little to no effect, leaving its overall impact unclear. Because of these conflicting results, a new meta-analysis was conducted to take a closer look and provide clearer answers. This study is one of the most thorough reviews to date, specifically examining how turmeric and curcumin influence body measurements in people with prediabetes and type 2 diabetes, and the results were published in Nutrition & Diabetes. How Was The Study Conducted? The researchers conducted a detailed review and analysis of studies to understand the effects of turmeric and curcumin on body measurements in people with prediabetes and type 2 diabetes. The reviewers carefully selected studies that met specific criteria, such as focusing on adults with prediabetes or diabetes and comparing turmeric/curcumin to a placebo. Studies on animals or pregnant women, as well as those combining turmeric with other treatments, were excluded. Twenty eligible articles were used for the systematic review and dose-response meta-analysis. What Did The Study Find? In the reevaluation of studies, the daily dose of turmeric or curcumin ranged from as low as 80 mg to as high as 2100 mg. The duration of these studies varied, too, lasting anywhere from eight weeks to 36 weeks. The interventions were categorized into three types: unformulated curcumin, high-absorption curcumin and turmeric. A total of 14 clinical trials studied the effects of turmeric or curcumin on body weight in people with type 2 diabetes. The combined results showed that turmeric/curcumin supplementation led to an average weight loss of 1.9 kg (or about 4.2 pounds) compared to the placebo. Additionally, participants with a body mass index (BMI) under 30 saw a greater weight reduction of 2.2 kg (about 4.8 pounds). These findings suggest turmeric may have an impact on weight management, especially in certain groups. Other findings included that among participants with type 2 diabetes, turmeric/curcumin supplementation modestly reduced waist and hip circumference, but had little effect on BMI and body fat percentage. As for people with prediabetes, three trials suggested that turmeric/curcumin supplements modestly reduced body weight when taken over 22 weeks, and turmeric/curcumin was also connected to a small reduction in waist circumference. While this study provides valuable insights into the potential benefits of turmeric and curcumin for managing body weight and measurements in people with prediabetes and type 2 diabetes, it has some limitations. The quality of evidence in many of the included trials was rated as low or very low, partly due to inconsistencies in results and differences in study designs, doses and durations. Additionally, the high variability between studies makes it harder to draw definitive conclusions. Most trials had small sample sizes, and some relied on self-reported data, which can introduce bias. Furthermore, the study excluded certain populations, such as pregnant women and those using turmeric alongside other treatments, limiting its generalizability. Finally, while turmeric and curcumin showed promise in some areas, the effects were often modest, highlighting that taking this supplement is unlikely to be a magic bullet for seeing noticeable outcomes for some. How Does This Apply To Real Life? If you're managing prediabetes or type 2 diabetes, the idea of adding a turmeric or curcumin supplement to your routine might sound appealing, especially since it's a natural and more budget-friendly option. The research suggests that turmeric could help with small but meaningful improvements in weight and waist size, particularly when taken in higher doses (over 1500 mg/day) or for longer periods (more than 22 weeks). That said, most turmeric or curcumin supplements usually have between 500 and 1,000 milligrams of curcumin per serving—and you should check in with a healthcare professional before taking a new supplement, especially one with a high dosage. For example, people with prediabetes saw an average weight loss of 2.5 kg (about 5.5 pounds) and a reduction in waist circumference of nearly 3 cm (about 1.2 inches). While these changes aren't dramatic, they could be a helpful addition to a broader plan that includes healthy eating, exercise, and regular medical care. That said, turmeric isn't a quick fix or a replacement for other treatments. Its effects are modest, and not everyone will see the same results. If you're considering turmeric or curcumin supplements, it's important to talk to your healthcare provider first, especially if you're already on medication for diabetes or other conditions. Supplements can interact with medications, and not all products are created equal. For example, some may not contain the right dose or form of curcumin to be effective. Ultimately, while turmeric shows promise, it works best as part of a well-rounded approach to managing diabetes and overall health. Our Expert Take This study, published in Nutrition & Diabetes, highlights the potential of turmeric as a natural, more budget-friendly supplement that may support weight management and reduce waist size in people with prediabetes and type 2 diabetes. But it is important to remember that while the results are promising, the effects are modest and vary depending on factors like dosage, duration and individual health conditions. Turmeric is not a cure-all, but it could serve as a helpful addition to a comprehensive diabetes management plan that includes a healthy diet, regular exercise and medical care. For those looking for alternative ways to support their health, turmeric offers a safe and accessible option worth considering under the guidance of your healthcare provider. Read the original article on EatingWell
Yahoo
an hour ago
- Yahoo
Medium-Duty Electric Trucks Gain Momentum Amid Stricter Emission Regulations
Growth is driven by the rising adoption of medium-duty electric trucks, bolstered by stringent emission regulations and urban delivery needs. The U.S. market is poised as a leader, supported by federal incentives and robust infrastructure investments. Electric Truck Market Dublin, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The "Electric Truck Market by Propulsion (BEV, PHEV, FCEV), Type (Light-duty Trucks, Medium-duty Trucks, Heavy-duty Trucks), Range, Battery Type, Battery Capacity, Level of Automation, End User, Payload Capacity, and Region - Global Forecast to 2032" has been added to electric truck market is anticipated to grow at a CAGR of 29.5%, reaching USD 32.13 billion by 2032 from USD 5.24 billion in 2025. The increase in medium-duty electric trucks is driven by stringent emission regulations and operational benefits for urban and regional delivery. Cities globally are implementing stricter vehicle emissions limits, bolstered by the rise of medium-duty trucks used for last-mile delivery. Electric trucks between Class 4 and Class 6 offer a zero-emission solution, meeting regulatory goals and supporting low-emission zone initiatives. Reduced noise levels make these trucks ideal for off-peak deliveries in urban locations. Companies like Ford and BYD have introduced medium-duty electric models designed for urban freight and field services. These trucks typically cover 150 to 200 miles per charge, sufficient for daily operations, and offer a lower total cost of ownership. Fleet operators are increasingly adopting these vehicles as sustainable and strategic assets, aligning with corporate ESG goals. The market is dominated by key players like BYD, AB Volvo, Ford Motor Company, Daimler Truck AG, and Dongfeng. The report segments the market based on propulsion, type, battery type, end users, range, payload capacity, and region, focusing on BEV, PHEV, and FCEV technology. Long-range Electric Trucks to See Fastest Growth Trucks with ranges above 200 miles will experience significant growth as fleet operators demand long-range solutions for regional logistics. This growth is supported by advancements in battery technology, with models like Tesla Semi and Freightliner eCascadia demonstrating extended capabilities. Long-range electric trucks are increasingly used in intercity transportation, contributing to productivity and cost efficiency. The rapid segment growth is bolstered by investments in high-capacity charging infrastructures, especially in the US, Canada, and Europe, where public and private initiatives are accelerating infrastructure deployment. Major logistics providers like PepsiCo and DHL are already exploring long-range electric trucks for operations. Stricter carbon regulations and incentives for zero-emission vehicles create favorable conditions for fleet transitions, making long-range electric trucks a valuable addition. As battery prices decline and range anxiety decreases, these trucks provide a compelling solution for decarbonizing operations without sacrificing logistical scope. The US Leads North American Electric Truck Market The US is poised to dominate the North American market, driven by federal regulations, state mandates, and electrification investments. The EPA and DOT have set stringent targets for vehicle emissions, accelerating the shift to electric alternatives, complemented by state policies like California's Advanced Clean Trucks rule. The Inflation Reduction Act further incentivizes commercial EV adoption, making it cost-effective for operators to transition. Leading companies such as Tesla, Ford, Rivian, and Freightliner are responding by increasing electric truck production to meet rising demand. The US market benefits from expanding charging infrastructure and significant participation from large logistics companies, with giants like Amazon and Walmart committing to electrifying their fleets. Key Attributes Report Attribute Details No. of Pages 301 Forecast Period 2025-2032 Estimated Market Value (USD) in 2025 $5.24 Billion Forecasted Market Value (USD) by 2032 $32.13 Billion Compound Annual Growth Rate 29.5% Regions Covered Global Key Topics CoveredMarket Dynamics Drivers Declining Battery Costs Government Initiatives Promoting Electric Commercial Vehicle Sales Increasing Range of Electric Trucks Growing Demand for Electric Trucks in Logistics and Other Industrial Sectors Restraints High Initial Investment for Production Lack of EV Charging Infrastructure Extended Charging Duration Opportunities Ongoing Development of Self-Driving Truck Technology Innovations in Fuel Cell Technology Challenges Limited Availability of Lithium for EV Batteries Inadequate Standardization of EV Charging Infrastructure Case Studies Battery-Electric Trucks Enhance User Experience in Norway Fortescue Employs Battery-Electric Trucks for Mining Operations Ruan Adopts Electric Terminal Trucks for Logistics Operations Company Profiles AB Volvo Daimler Truck AG Ford Motor Company Dongfeng Motor Corporation Rivian BYD Company Ltd. Tesla, Inc. Scania Paccar Inc. Foton International VDL Groep Workhorse Group Tata Motors Limited Ashok Leyland Isuzu Motors Ltd. Irizar Group Iveco S.p.A Bollinger Motors Xos Trucks, Inc. Man SE Kaiyun Motors Zhejiang Geely New Energy Commercial Vehicle Group Co. Ltd. Orange EV Hino Motors, Ltd. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Electric Truck Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio